Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) Return on Sales (2024 - 2025)

Historic Return on Sales for Incannex Healthcare (IXHL) over the last 2 years, with Q4 2025 value amounting to 1304.2%.

  • Incannex Healthcare's Return on Sales fell 8130300.0% to 1304.2% in Q4 2025 from the same period last year, while for Dec 2025 it was 4849.9%, marking a year-over-year decrease of 45734300.0%. This contributed to the annual value of 545.17% for FY2025, which is 9930800.0% up from last year.
  • As of Q4 2025, Incannex Healthcare's Return on Sales stood at 1304.2%, which was down 8130300.0% from 1281.4% recorded in Q3 2025.
  • Incannex Healthcare's Return on Sales' 5-year high stood at 73.24% during Q3 2024, with a 5-year trough of 1304.2% in Q4 2025.